<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="82657">
  <stage>Registered</stage>
  <submitdate>6/03/2008</submitdate>
  <approvaldate>2/04/2008</approvaldate>
  <actrnumber>ACTRN12608000154303</actrnumber>
  <trial_identification>
    <studytitle>Screening for Colorectal Cancer in Recipients of Kidney Transplants</studytitle>
    <scientifictitle>Screening for Colorectal Cancer with Faecal Occult Blood Testing and Colonoscopy in Kidney Transplant recipients: a prospective cross-sectional study.</scientifictitle>
    <utrn />
    <trialacronym />
    <secondaryid>Screnning for Colorectal Cancer in Recipients of Kidney Transplants</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Kidney Transplantation - post transplant malignancy</healthcondition>
    <healthcondition>Colorectal Cancer</healthcondition>
    <conditioncode>
      <conditioncode1>Cancer</conditioncode1>
      <conditioncode2>Bowel - Back passage (rectum) or large bowel (colon)</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>1. Faecal occult blood testing (FOBT). Participants will perform FOBT following enrolment. This involves using a patient kit to sample their own stools for the presence of blood, mailing their testing kit in to a central lab once it is completed. Testing will be conducted once but may involve sampling several stools.
2. Colonoscopy. All participants will also undergo colonoscopy following the completion of FOBT, regardless of the result. This will be performed within a target of 3 months post enrolment.</interventions>
    <comparator>General population offered Colorectal cancer screening with faecal occult blood testing (followed up by colonoscopy if positive).</comparator>
    <control>Historical</control>
    <interventioncode>Early detection / Screening</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Sensitivity and specificity of faecal occult blood testing for colorectal cancer and colorectal neoplasia, using colonscopy as the "gold standard" procedure.</outcome>
      <timepoint>One-off screening with both FOBT and colonoscopy, with a completion target of 3 months post enrolment.</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Rate of Colorectal Cancer and colorectal neoplasia found at screening colonoscopy.</outcome>
      <timepoint>One-off screening colonoscopy, with a completion target of 3 months post enrolment.</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>- Kidney transplant recipients in South Australia &gt;=50 years old, more than 6 months post transplant
- Willing and able to give informed consent</inclusivecriteria>
    <inclusiveminage>50</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>0</inclusivemaxage>
    <inclusivemaxagetype>No limit</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>- Active unstable cardiopulmonary disease
- Terminal illness, life threatening malignancy
- Bleeding disorders or unable to stop oral anti-coagulants for colonoscopy
- Colonoscopy within 12 months prior to enrolment
- Failed kidney transplant and return to dialysis prior to enrolment
- Symptoms or signs suggestive of colorectal cancer
- Previous personal history of colorectal cancer, advanced adenoma or chronic ulcerative colitis
- Family history of Familial Adenomatous Polyposis (FAP) or Hereditary non-polyposis colorectal cancer (HNPCC)</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Observational</studytype>
    <purpose />
    <allocation />
    <concealment />
    <sequence />
    <masking />
    <assignment />
    <designfeatures />
    <endpoint />
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs>Screening</purposeobs>
    <duration>Cross-sectional</duration>
    <selection>Defined population</selection>
    <timing>Prospective</timing>
  </trial_design>
  <recruitment>
    <phase>Not Applicable</phase>
    <anticipatedstartdate>1/06/2008</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>450</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Completed</recruitmentstatus>
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate />
    <postcode>5011</postcode>
    <postcode>5000</postcode>
    <postcode>5042</postcode>
    <postcode>5041</postcode>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Individual</primarysponsortype>
    <primarysponsorname>Dr Michael Collins</primarysponsorname>
    <primarysponsoraddress>Central Northern Adelaide Renal and Transplantation Service,
Royal Adelaide Hospital
North Terrace
Adelaide SA 5000</primarysponsoraddress>
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Hospital</fundingtype>
      <fundingname>Queen Elizabeth Hospital</fundingname>
      <fundingaddress>28 Woodville Road
Woodville South South Australia 5011</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <fundingsource>
      <fundingtype>Hospital</fundingtype>
      <fundingname>Flinders Medical Centre</fundingname>
      <fundingaddress>Flinders Drive
Bedford Park South Australia 5042</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <fundingsource>
      <fundingtype>Hospital</fundingtype>
      <fundingname>Repatriation General Hospital</fundingname>
      <fundingaddress>Daws Road
Daws Park South Australia 5041</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>Individual</sponsortype>
      <sponsorname>Associate Professor Toby Coates</sponsorname>
      <sponsoraddress>Central Northern Adelaide Renal and Transplantation Service,
Royal Adelaide Hospital
North Terrace
Adelaide SA 5000</sponsoraddress>
      <sponsorcountry>Australia</sponsorcountry>
    </secondarysponsor>
    <secondarysponsor>
      <sponsortype>Individual</sponsortype>
      <sponsorname>Associate Professor Stephen McDonald</sponsorname>
      <sponsoraddress>Central Northern Adelaide Renal and Transplantation Service,
Royal Adelaide Hospital
North Terrace
Adelaide SA 5000</sponsoraddress>
      <sponsorcountry>Australia</sponsorcountry>
    </secondarysponsor>
    <othercollaborator>
      <othercollaboratortype>Individual</othercollaboratortype>
      <othercollaboratorname>Professor Graeme Russ</othercollaboratorname>
      <othercollaboratoraddress>Central Northern Adelaide Renal and Transplantation Service,
Royal Adelaide Hospital
North Terrace
Adelaide SA 5000</othercollaboratoraddress>
      <othercollaboratorcountry>Australia</othercollaboratorcountry>
    </othercollaborator>
    <othercollaborator>
      <othercollaboratortype>Individual</othercollaboratortype>
      <othercollaboratorname>Professor Graeme Young</othercollaboratorname>
      <othercollaboratoraddress>Department of Gastroenterology and Hepatology and Flinders Centre for Innovation in Cancer
Flinders Medical Centre
Bedford Park South Australia 5042</othercollaboratoraddress>
      <othercollaboratorcountry>Australia</othercollaboratorcountry>
    </othercollaborator>
    <othercollaborator>
      <othercollaboratortype>Individual</othercollaboratortype>
      <othercollaboratorname>Associate Professor Peter Bampton</othercollaboratorname>
      <othercollaboratoraddress>Department of Gastroenterology and Hepatology Flinders Medical Centre
Bedford Park South Australia 5042</othercollaboratoraddress>
      <othercollaboratorcountry>Australia</othercollaboratorcountry>
    </othercollaborator>
    <othercollaborator>
      <othercollaboratortype>Individual</othercollaboratortype>
      <othercollaboratorname>Mr Steve Cole</othercollaboratorname>
      <othercollaboratoraddress>Bowel Health Service and Department of Medicine
Flinders University of South Australia
Repatriation General Hospital
Daws Road
Daws Park South Australia 5041</othercollaboratoraddress>
      <othercollaboratorcountry>Australia</othercollaboratorcountry>
    </othercollaborator>
  </sponsorship>
  <ethicsAndSummary>
    <summary>The risk of cancer, including colorectal cancer is increased in recipients of kidney transplants. This study is designed to evaluate the standard population screening tools for colorectal cancer, ie faecal occult blood testing and colonoscopy, in this high risk population. All recruited patients will undergo both of these screening tests, and from this we will investigate the rates of colorectal cancer and pre-cancerous growths in this population, and the usefulness of the two screening tests for this group of patients.</summary>
    <trialwebsite />
    <publication>Preliminary results from the study have been presented in abstract form at the following conferences:
1. The Transplantation Society Congress, August 2010 (Vancouver, Canada)
2. Australian and New Zealand Society of Nephrology Annual Scientific Meeting, September 2010 (Perth, Australia)
2. American Transplant Congress, May 2011 (Philadelphia, USA)
2. Transplantation Society of Australia and NZ, June 2011 (Canberra, Australia)</publication>
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Central Northern Adelaide Health Service Ethics of Human Research Committee</ethicname>
      <ethicaddress>Research Secretariat
Ground Floor, Basil Hetzel Institute
Queen Elizabeth Hospital
28 Woodville Road
Woodville South SA 5011</ethicaddress>
      <ethicapprovaldate>17/03/2008</ethicapprovaldate>
      <hrec>2008043</hrec>
      <ethicsubmitdate />
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
    <ethicscommitee>
      <ethicname>Royal Adelaide Hospital Research Ethics Committee</ethicname>
      <ethicaddress>Royal Adelaide Hospital
North Terrace
Adelaide SA 5000</ethicaddress>
      <ethicapprovaldate>15/05/2008</ethicapprovaldate>
      <hrec>080510</hrec>
      <ethicsubmitdate />
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
    <ethicscommitee>
      <ethicname>Flinders Clinical Research Ethics Committee</ethicname>
      <ethicaddress>Flinders Medical Centre
Bedford Park, SA 5042</ethicaddress>
      <ethicapprovaldate>24/06/2008</ethicapprovaldate>
      <hrec>118/08</hrec>
      <ethicsubmitdate />
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Dr Michael Collins</name>
      <address>Central Northern Adelaide Renal and Transplantation Service,
Royal Adelaide Hospital
North Terrace
Adelaide SA 5000</address>
      <phone>+61 8 82220900</phone>
      <fax>+61 8 82220970</fax>
      <email>michael.collins@health.sa.gov.au</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name>Dr Michael Collins</name>
      <address>Central Northern Adelaide Renal and Transplantation Service,
Royal Adelaide Hospital
North Terrace
Adelaide SA 5000</address>
      <phone>+61 8 82220900</phone>
      <fax>+61 8 82220970</fax>
      <email>michael.collins@health.sa.gov.au</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name>Dr Michael Collins</name>
      <address>Central Northern Adelaide Renal and Transplantation Service,
Royal Adelaide Hospital
North Terrace
Adelaide SA 5000</address>
      <phone>+61 8 82220900</phone>
      <fax>+61 8 82220970</fax>
      <email>michael.collins@health.sa.gov.au</email>
      <country>Australia</country>
      <type>Updating Information</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>